[1]
2026. Comparison of intravitreal ranibizumab and aflibercept in patients with choroidal neovascularization in pathologic myopia. Ukrainian Journal of Ophthalmology . 5 (Jun. 2026), 34–38. DOI:https://doi.org/10.31288/oftalmolzh201753438.